No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Positive CHMP Opinion for Amgen’s ustekinumab Biosimilar (Wezenla™)
On 25 April 2024, EMA’s Committee for Medicinal Products for Human Use (CHMP) issued a positive recommendation for Amgen's Wezenla™ (ustekinumab), biosimilar to Janssen's Stelara®. Wezenla™ is proposed to be available in a 45 mg and 90 mg solution for injection, as...